Is Resonance Speci. overvalued or undervalued?

As of 19 November 2025, the valuation grade for Resonance Speci. has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.61, an EV to EBITDA of 9.79, and a PEG ratio of 0.23, which suggests that the stock may be undervalued relative to its growth prospects.
In comparison to its peers, Resonance Speci. has a PE ratio that is significantly lower than Solar Industries, which stands at 94.38, and Gujarat Fluoroch at 56.8, both of which are considered very expensive. This positions Resonance Speci. favorably within the specialty chemicals sector, especially considering its solid ROCE of 15.09% and ROE of 11.32%. Despite recent stock performance lagging behind the Sensex over the past year, the long-term return of 378.54% over the last decade highlights its potential for growth.